Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...

Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.

Short interest in Hims & Hers Health Inc rose to a record high, even as shares surged following strong first-quarter results.

We recently published an article titled These 10 Stocks Moved the Market This Week, Here’s Why. In this article, we are going ...

Hims & Hers (NYSE: HIMS) stock has been on fire in 2025, and the company just got more great news after upsizing a $450 million convertible debt offering to up to $1 billion. The growth of Hims & Hers ...

Former Meta and Time Warner exec Mark D'Arcy is joining Microsoft as a corporate vice president working on the tech ...

Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...

Nader Kabbani, who led the launch of Amazon Pharmacy and the acquisition of PillPack, will take the chief operating officer ...

Nader Kabbani, who spent almost 20 years at the e-commerce giant, joins the health startup as chief operations officer.

Hims & Hers Health Inc (NYSE:HIMS) shares are falling Thursday morning after the company announced a proposed convertible ...

As Stat reports, the federal judge's ruling means patients will lose access to less-expensive versions of Eli Lilly's weight loss drug, as well as diabetes treatment Mounjaro, from compounding ...

The decline in Hims & Hers’ stock price comes as the market reacts to the potential dilution of shares resulting from the ...